These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9513472)

  • 21. The validity of predicted body fat percentage from body mass index and from impedance in samples of five European populations.
    Deurenberg P; Andreoli A; Borg P; Kukkonen-Harjula K; de Lorenzo A; van Marken Lichtenbelt WD; Testolin G; Vigano R; Vollaard N
    Eur J Clin Nutr; 2001 Nov; 55(11):973-9. PubMed ID: 11641746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of leptin with insulin resistance, body composition, and lipid parameters in postmenopausal women and men in type 2 diabetes mellitus.
    Gulturk S; Cetin A; Erdal S
    Saudi Med J; 2008 Jun; 29(6):813-20. PubMed ID: 18521457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension in obese and non-obese non-insulin dependent diabetics a matter of regional adiposity?
    Van Gaal LF; Nobels FR; Rillaerts EG; Creten WL; De Leeuw IH
    Diabete Metab; 1988; 14(3):289-93. PubMed ID: 3410153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
    Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
    Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total and regional fat and serum cardiovascular disease risk factors in lean and obese children and adolescents.
    Teixeira PJ; Sardinha LB; Going SB; Lohman TG
    Obes Res; 2001 Aug; 9(8):432-42. PubMed ID: 11500523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Regional differences in fat metabolism--diabetogenic and atherogenic obesity].
    Vague J; Vague P; Jubelin J; Barre A
    Harefuah; 1989 Dec; 117(12):437-41. PubMed ID: 2695425
    [No Abstract]   [Full Text] [Related]  

  • 27. Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy.
    Tankó LB; Christiansen C
    Climacteric; 2006 Jun; 9(3):169-80. PubMed ID: 16766431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body composition phenotypes in pathways to obesity and the metabolic syndrome.
    Dulloo AG; Jacquet J; Solinas G; Montani JP; Schutz Y
    Int J Obes (Lond); 2010 Dec; 34 Suppl 2():S4-17. PubMed ID: 21151146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex-specific determinants of left ventricular mass in pre-diabetic and type 2 diabetic subjects: the Augsburg Diabetes Family Study.
    Kuch B; von Scheidt W; Peter W; Döring A; Piehlmeier W; Landgraf R; Meisinger C
    Diabetes Care; 2007 Apr; 30(4):946-52. PubMed ID: 17392555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of adiposity phenotypes from childhood and adolescence into young adulthood with contribution of parental measures.
    Campbell PT; Katzmarzyk PT; Malina RM; Rao DC; Pérusse L; Bouchard C
    Obes Res; 2001 Jul; 9(7):394-400. PubMed ID: 11445661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Techniques for the measurement of body composition and body fat distribution].
    Katsukawa F; Kataoka K
    Nihon Rinsho; 1997 Mar; 55 Suppl 1():282-6. PubMed ID: 9097605
    [No Abstract]   [Full Text] [Related]  

  • 32. What aspects of body fat are particularly hazardous and how do we measure them?
    Snijder MB; van Dam RM; Visser M; Seidell JC
    Int J Epidemiol; 2006 Feb; 35(1):83-92. PubMed ID: 16339600
    [No Abstract]   [Full Text] [Related]  

  • 33. Mapping fat: where your flab is stored matters, spurring scientists to develop new ways to assess your health.
    Gebel E
    Diabetes Forecast; 2013 Apr; 66(4):46-9. PubMed ID: 23638473
    [No Abstract]   [Full Text] [Related]  

  • 34. Body fat and increased risk of cirrhosis.
    Byrne CD; Wild SH
    BMJ; 2010 Mar; 340():c774. PubMed ID: 20223874
    [No Abstract]   [Full Text] [Related]  

  • 35. Abdominal obesity and the "hypertriglyceridaemic waist" phenotype.
    Little P; Byrne CD
    BMJ; 2001 Mar; 322(7288):687-9. PubMed ID: 11264193
    [No Abstract]   [Full Text] [Related]  

  • 36. Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients.
    Satoh N; Naruse M; Usui T; Tagami T; Suganami T; Yamada K; Kuzuya H; Shimatsu A; Ogawa Y
    Diabetes Care; 2004 Oct; 27(10):2488-90. PubMed ID: 15451921
    [No Abstract]   [Full Text] [Related]  

  • 37. [Visceral fat syndrome and arteriosclerosis].
    Matsuzawa Y
    Nihon Naika Gakkai Zasshi; 1997 Mar; 86(3):369-73. PubMed ID: 9198613
    [No Abstract]   [Full Text] [Related]  

  • 38. [Near infrared interactance for measurement of body fat mass].
    Sawai S; Miyashita M
    Nihon Rinsho; 1995 Jun; 53 Suppl():183-8. PubMed ID: 7563692
    [No Abstract]   [Full Text] [Related]  

  • 39. Cancer prognosis: role of BMI and fat tissue.
    Azvolinsky A
    J Natl Cancer Inst; 2014 Jun; 106(6):dju177. PubMed ID: 24907390
    [No Abstract]   [Full Text] [Related]  

  • 40. Differentiating between body fat and lean mass-how should we measure obesity?
    Romero-Corral A; Lopez-Jimenez F; Sierra-Johnson J; Somers VK
    Nat Clin Pract Endocrinol Metab; 2008 Jun; 4(6):322-3. PubMed ID: 18382423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.